Načítá se...
Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
Bone is one of the most preferred sites of metastasis in lung cancer. Currently, bisphosphonates and denosumab are major agents for controlling tumor-associated skeletal-related events (SREs). However, both bisphosphonates and denosumab significantly increase the risk for jaw osteonecrosis. Statins,...
Uloženo v:
| Vydáno v: | EBioMedicine |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5440603/ https://ncbi.nlm.nih.gov/pubmed/28454732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2017.04.017 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|